留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性甲状旁腺功能亢进症患者术前维生素D补充的有效性和安全性

薛瑜 王鸥 邢小平

薛瑜, 王鸥, 邢小平. 原发性甲状旁腺功能亢进症患者术前维生素D补充的有效性和安全性[J]. 协和医学杂志, 2015, 6(5): 376-380. doi: 10.3969/j.issn.1674-9081.2015.05.013
引用本文: 薛瑜, 王鸥, 邢小平. 原发性甲状旁腺功能亢进症患者术前维生素D补充的有效性和安全性[J]. 协和医学杂志, 2015, 6(5): 376-380. doi: 10.3969/j.issn.1674-9081.2015.05.013

原发性甲状旁腺功能亢进症患者术前维生素D补充的有效性和安全性

doi: 10.3969/j.issn.1674-9081.2015.05.013
基金项目: 

国家自然科学基金青年基金 81100559

面上项目 81270873

详细信息
    通讯作者:

    邢小平 电话:010-69155084, E-mail:xingxp2006@126.com

  • 中图分类号: R582+.1

  • [1] Fraser WD. Hyperparathyroidism[J]. Lancet, 2009, 374:145-158. doi:  10.1016/S0140-6736(09)60507-9
    [2] Pallan S, Khan A. Primary hyperparathyroidism:update on presentation, diagnosis, and management in primary care[J]. Can Fam Physician, 2011, 57:184-189. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038812/?tool=pubmed
    [3] Orwoll E, Nielson CM, Marshall LM, et al. Vitamin D deficiency in older men[J]. J Clin Endocrinol Metab, 2009, 94:1214-1222. doi:  10.1210/jc.2008-1784
    [4] Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults[J]. Nutr Res, 2011, 31:48-54. doi:  10.1016/j.nutres.2010.12.001
    [5] Jacques PF, Felson DT, Tucker KL, et al. Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample[J]. Am J Clin Nutr, 1997, 66:929-936. doi:  10.1093/ajcn/66.4.929
    [6] Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitamin D status of the US population:1988-1994 compared with 2000-2004[J]. Am J Clin Nutr, 2008, 88:1519-1527. doi:  10.3945/ajcn.2008.26182
    [7] Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women:confirmation of reversal of secondary hyperparathyroidism and hip fracture risk:the Decalyos Ⅱ study[J]. Osteoporos Int, 2002, 13:257-264. doi:  10.1007/s001980200023
    [8] Tribedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community:randomized double blind controlled trial[J]. BMJ, 2003, 326:469. doi:  10.1136/bmj.326.7387.469
    [9] Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women:a randomized controlled trial[J]. JAMA, 2010, 303:1815-1822. doi:  10.1001/jama.2010.594
    [10] Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement:vitamin D recommendations for older adults[J]. Osteoporos Int, 2010, 21:1151-1154. doi:  10.1007/s00198-010-1285-3
    [11] Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency:an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2011, 96:1911-1930. doi:  10.1210/jc.2011-0385
    [12] Holick MF.High prevalence of vitamin D inadequacy and implications for health[J]. Mayo Clin Proc, 2006, 81:353-373. doi:  10.4065/81.3.353
    [13] Vieth R. What is the optimal vitamin D status for health?[J]. Prog Biophys Mol Biol, 2006, 92:26-32. doi:  10.1016/j.pbiomolbio.2006.02.003
    [14] Silverberg SJ, Shane E, Dempster DW, et al. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism[J]. Am J Med, 1999, 107:561-567. doi:  10.1016/S0002-9343(99)00294-6
    [15] Saliba W, Lavi I, Rennert HS, et al. Vitamin D status in primary hyperparathyroidism[J]. Eur J Intern Med, 2012, 23:88-92. doi:  10.1016/j.ejim.2011.07.008
    [16] Moosgaard B, Vestergaard P, Heickendorff L, et al. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism[J]. Clin Endocrinol, 2005, 63:506-513. doi:  10.1111/j.1365-2265.2005.02371.x
    [17] Clements MR, Davies M, Hayes ME, et al. The role of 1, 25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency[J]. Clin Endocrinol, 1992, 37:17-27. doi:  10.1111/j.1365-2265.1992.tb02278.x
    [18] Clements MR, Davies M, Fraser DR, et al. Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism[J]. Clin Sci, 1987, 73:659-664. doi:  10.1042/cs0730659
    [19] Moosgaard B, Christensen SE, Vestergaard P, et al. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism[J]. Clin Endocrinol, 2008, 68:707-715. doi:  10.1111/j.1365-2265.2007.03109.x
    [20] Carnevale V, Manfredi G, Romagnoli E, et al. Vitamin D status in female patients with primary hyperparathyroidism:does it play a role in skeletal damage?[J]. Clin Endocrinol, 2004, 60:81-86. doi:  10.1111/j.1365-2265.2004.01946.x
    [21] Velayoudom-Cephise FL, Foucan L, Soudan B, et al. Half of the patients with primary hyperparathyroidism have a vitamin D deficiency:aggravating the osseous attack[J]. Presse Med, 2011, 40:e120-e127. doi:  10.1016/j.lpm.2010.08.005
    [22] Rao DS, Honasoge M, Divine GW, et al. Effect of vitamin D nutrition on parathyroid adenoma weight:pathogenetic and clinical implications[J]. J Clin Endocrinol Metab, 2000, 85:1054-1058. http://so.med.wanfangdata.com.cn/ViewHTML/PeriodicalPaper_JJ0210461954.aspx
    [23] Ozbey N, Erbil Y, Ademoglu E, et al. Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism[J]. World J Surg, 2006, 30:321-326. doi:  10.1007/s00268-005-0239-y
    [24] Grubbs EG, Rafeeq S, Jimenez C, et al. Preoperative vitamin D replacement therapy in primary hyperparathyroidism:safe and beneficial?[J]. Surgery, 2008, 144:852-858. doi:  10.1016/j.surg.2008.06.032
    [25] Brown EM. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue[J]. J Clin Endocrinol Metab, 1983, 56:572-581. doi:  10.1210/jcem-56-3-572
    [26] Kantorovich V, Gacad MA, Seeger LL, et al. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism[J]. J Clin Endocrinol Metab, 2000, 85:3541-3543. http://labs.europepmc.org/abstract/MED/11061498/reload=1;jsessionid=X2X8mBH5ozIZ2iNFC4f1.43
    [27] Grey A, Lucas J, Horne A, et al. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency[J]. J Clin Endocrinol Metab, 2005, 90:2122-2126. doi:  10.1210/jc.2004-1772
    [28] Tucci JR. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D[J]. Eur J Endocrinol, 2009, 161:189-193. doi:  10.1530/EJE-08-0901
    [29] Isidro ML, Ruano B.Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency[J]. Endocrine, 2009, 36:305-310. doi:  10.1007/s12020-009-9211-1
    [30] Rao RR, Randeva HS, Sankaranarayanan S, et al. Prolonged treatment with vitamin D in postmenopausal women with primary hyperparathyroidism[J]. Endocr Connect, 2012, 1:13-21. doi:  10.1530/EC-12-0008
    [31] Wagner D, Xia Y, Hou R. Safety of vitamin D replacement in patients with primary hyperparathyroidism and concomitant vitamin D deficiency[J]. Endocr Pract, 2013, 19:420-425. doi:  10.4158/EP12155.OR
    [32] Rathi MS, Gonzalez S, Wright D, et al. Management of hypovitaminosis D in patients with primary hyperparathyroidism[J]. J Endocrinol Invest, 2014, 37:467-471. doi:  10.1007/s40618-014-0056-y
    [33] Rolighed L, Rejnmark L, Sikjaer T, et al. Vitamin D treatment in primary hyperparathyroidism:a randomized placebo controlled trial[J]. J Clin Endocrinol Metab, 2014, 99:1072-1080. doi:  10.1210/jc.2013-3978
    [34] Das G, Eligar V, Govindan J, et al. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency[J]. Ann Clin Biochem, 2015, 52:462-469. doi:  10.1177/0004563214564400
  • 加载中
计量
  • 文章访问数:  106
  • HTML全文浏览量:  40
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-07-14
  • 刊出日期:  2015-09-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!